Navigation Links
DAIICHI SANKYO EUROPE GmbH Selects DATATRAK eClinical™ for Pan-European Systolic Hypertension Study
Date:8/2/2010

CLEVELAND, Aug. 2 /PRNewswire-FirstCall/ -- DATATRAK International, Inc. (OTCQX: DATA), a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that DAIICHI SANKYO EUROPE GmbH has selected DATATRAK's eClinical™ platform for a cardiovascular clinical study encompassing 80 sites and 1,200 patients across Europe. Reaping the benefits of a unified platform, DAIICHI SANKYO EUROPE GmbH will utilize DATATRAK's Electronic Data Capture solution in addition to web-based Patient Randomization, Drug Inventory Management, Lab Import and Auto-Coding Engine solutions. Also, study users will be able to view, manage and report on patient data via DATATRAK's dynamic, ad-hoc reporting module. As with all studies for this sponsor, DATATRAK will be producing CDISC SDTM compliant exports throughout the study.

"We have decided to use DATATRAK because the unified platform appealed to our needs. The ease in which for example IWRS or study drug management can be utilized with EDC within one solution will bring us significant benefit throughout the study. Furthermore, the built-in data export routines to SDTM and flexible ad-hoc reporting tools supporting our efforts in process control," said Paul-Egbert Reimitz, Director of Biostatistics and Data Operations at DAIICHI SANKYO EUROPE GmbH.

"We are delighted to have been awarded this new study by DAIICHI SANKYO EUROPE, whose adoption of DATATRAK ONE™ is a testament to both teams' hard work and success in implementing complex international clinical trials," said Laurence P. Birch, DATATRAK's Chairman of the Board. "We remain focused on providing our clients the benefits of increased patient safety, real-time data availability
'/>"/>

SOURCE DATATRAK International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB
2. Daiichi Sankyo, Inc. Names Dr. Jay Feingold Vice President, Medical Affairs
3. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
4. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
5. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
6. ApoA-I Data Presented at European Society of Cardiology Congress
7. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
8. CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
9. Quark Pharmaceuticals Announces Poster Presentations at RNAi Europe 2008
10. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
11. Kuvan Receives Positive Opinion From CHMP for European Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/27/2014)... 2014 Called the NOAH Protocol, ... several types of pediatric brain cancer. The implications ... over 30 years of research and development. Amber ... that one mom's determination can make a difference. ... trick-or-treating, and it’s only fitting that we’ve received ...
(Date:10/27/2014)... , Oct. 27, 2014 Pressure ... a worldwide leader in the development and sale ... life sciences research market, today announced that Professor ... a novel, accurate, highly reproducible, and robust method ... routine high-throughput protein analysis on small needle biopsy ...
(Date:10/27/2014)... Investor-Edge has initiated coverage on ... NBIX ), Insmed Inc. (NASDAQ: INSM ), ... Corporation (NASDAQ: DYAX ), and Oncothyreon Inc. ... be accessed at: http://investor-edge.com/register . On ... 4,483.72, up 0.69%, the Dow Jones Industrial Average advanced ...
(Date:10/26/2014)... The report "Protective Coatings Market by Resin Type, by ... to 2019", defines and segments the global protective coatings ... value generated. The protective coatings consumption is projected to ... by 2019, at a CAGR of 9.52% during the ... 22 figures spread through 219 slides and in-depth TOC ...
Breaking Biology Technology:FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 2FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 3Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 2Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 3Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 4Breakthrough Method to Permit Quantification of Thousands of Proteins in Needle Biopsy Samples in 12 hours Presented at Major International Scientific Meeting; Method Enabled by Pressure BioSciences' PCT Sample Preparation Platform 5Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 2Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 3Protective Coatings Market Poised to Reach $18,431.8 Million by 2019 - Report by MarketsandMarkets 4
... February 5, SAN DIEGO, Jan. 24 Neurocrine ... Company will report its fourth,quarter and year-end 2007 financial ... 2008. Neurocrine will then host a live conference,call and ... Company,update Tuesday afternoon, February 5, 2008 at 5:00 p.m. ...
... Jan. 24 Biomatrica, the biostability company,that offers ... has introduced RNAstable(TM) for preserving RNA at room,temperature, ... Interest in RNA has skyrocketed over the ... silencer and in gene expression studies. However, RNA ...
... Jan. 24 Aton Pharma, Inc., ... that it has,launched an expanded, comprehensive ... and patient education resources, for the,dry ... Lacrisert is a unique preservative-free, once-daily*, ...
Cached Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2007 Financial Results 2Biomatrica's RNAstable(TM) Stabilizes RNA at Room Temperature 2Biomatrica's RNAstable(TM) Stabilizes RNA at Room Temperature 3Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye 2Aton Pharma Introduces Expanded Distribution of Lacrisert(R) (hydroxypropyl cellulose ophthalmic insert) at Hawaiian Eye 3
(Date:10/29/2014)... research by the international Cancer Genomics of the ... connection between kidney cancer and exposure to aristolochic ... findings, published in Nature Communications , have ... kills more than 140,000 people every year, and ... dramatically. CAGEKID, part of the International Cancer Genome ...
(Date:10/28/2014)... the tragic realities of cancer is that the ... and their effectiveness varies unpredictably from patient to ... to change this reality by rapidly assessing how ... individual,s cancer before chemotherapy begins. , A team ... Assistant Professor Melissa Skala has developed the technique, ...
(Date:10/28/2014)... from North America, Europe and China have published a ... of Sciences that reveals important details about key ... planet., From strange and exotic algae, mosses, ferns, trees ... grains and vegetables we eat and the ornamental plants ... over a billion years of history., "Our study generated ...
Breaking Biology News(10 mins):Kidney cancer in Central Europe 2Improving breast cancer chemo by testing patient's tumors in a dish 2Improving breast cancer chemo by testing patient's tumors in a dish 3New study uses DNA sequences to look back in time at key events in plant evolution 2New study uses DNA sequences to look back in time at key events in plant evolution 3
... An entire group of millipedes previously unknown in ... shelves. Hundreds of tiny specimens of the widespread tropical family ... showing that native pyrgodesmids are not only widespread ... and diverse. The study has been published in the open ...
... 2012For many diabetics, monitoring their condition involves much more ... insulin injections. It also entails carefully monitoring the ongoing ... An innovative new optical diagnostic tool created by Columbia ... (OSA) open-access journal Biomedical Optics Express may ...
... of Leicester medical scientists have secured funding for a ... into children,s breathing. The team of researchers working ... Exhalyzer-D, a highly-specialised device made in Switzerland. ... grants from Midlands Asthma and Allergy Research Association (MAARA) ...
Cached Biology News:Millipede family added to Australian fauna 2Shedding new light on one of diabetes' most dangerous complications 2New equipment is breath of fresh air for children's lung researchers 2
... dispensers save space and organize gloves, ... garb. They are the perfect benchtop ... in labs, processing and manufacturing. Clear ... the particles they attract. Open-slot design ...
... critical to the maintenance of appropriate ... as important and diverse as those ... and stress response, antigen presentation, modulation ... channels, cell cycle regulation, transcription, and ...
... Pooled Human Serum • Human serum is ... found to be negative by a test ... Antibodies to Human Immunodeficiency Virus (Anti-HIV 1/2), ... Hepatitis B Surface Antigen (HbsAg) and Non-reactive ...
... Cleanroom-grade vinyl curtains or ... powder-coated steel support frame to ... cleanroom that meets cleanliness to ... HEPA filter/fan units, lights, and ...
Biology Products: